Antibody Directed Enzyme Prodrug Therapy (ADEPT) and Related Approaches for Anticancer Therapy
Author: Jung M.
Source: Mini Reviews in Medicinal Chemistry, Volume 1, Number 4, November 2001 , pp. 399-407(12)
Publisher: Bentham Science Publishers
Abstract:
In antibody directed enzyme prodrug therapy (ADEPT) an antibody bound enzyme is targeted to tumor cells. This allows for selective activation of a nontoxic prodrug to a cytotoxic agent at the tumor site for cancer therapy. Site-selective prodrug activation results in reduced side effects in remote tissue. This article reviews ADEPT with emphasis on the chemical viewpoint and recent developments.
Keywords: Antibody Directed Enzyme Prodrug Therapy; ADEPT; Anticancer Therapy; Alkaline Phosphatase; Amino Peptidases; Aryl Sulfatase; Carboxylesterase; Carboxypeptidase A; Carboxypeptidase G2 (CpG2); Cytosine Deaminase
Language: English
Document Type: Review article
DOI: http://dx.doi.org/10.2174/1389557013406747
Publication date: 2001-11-01
- The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.
The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.
Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
- In this: publication
- By this: publisher
- In this Subject: Chemistry (General) , Pharmacology
- By this author: Jung M.

Shopping cart
Receive new issue alert
Get Permissions